Progress Toward Regional Measles Elimination - Worldwide, 2000-2015
- PMID: 27832050
- DOI: 10.15585/mmwr.mm6544a6
Progress Toward Regional Measles Elimination - Worldwide, 2000-2015
Abstract
Adopted in 2000, United Nations Millennium Development Goal 4 set a target to reduce child mortality by two thirds by 2015, with measles vaccination coverage as one of the progress indicators. In 2010, the World Health Assembly (WHA) set three milestones for measles control by 2015: 1) increase routine coverage with the first dose of measles-containing vaccine (MCV1) for children aged 1 year to ≥90% nationally and ≥80% in every district; 2) reduce global annual measles incidence to <5 cases per 1 million population; and 3) reduce global measles mortality by 95% from the 2000 estimate (1,2).* In 2012, WHA endorsed the Global Vaccine Action Plan† with the objective to eliminate measles in four World Health Organization (WHO) regions by 2015. Countries in all six WHO regions have adopted measles elimination goals. Measles elimination is the absence of endemic measles transmission in a region or other defined geographical area for ≥12 months in the presence of a well performing surveillance system. This report updates a previous report (3) and describes progress toward global measles control milestones and regional measles elimination goals during 2000-2015. During this period, annual reported measles incidence decreased 75%, from 146 to 36 cases per 1 million persons, and annual estimated measles deaths decreased 79%, from 651,600 to 134,200. However, none of the 2015 milestones or elimination goals were met. Countries and their partners need to act urgently to secure political commitment, raise the visibility of measles, increase vaccination coverage, strengthen surveillance, and mitigate the threat of decreasing resources for immunization once polio eradication is achieved.
Comment in
-
Measles vaccination: global progress, local challenges.Lancet. 2016 Nov 19;388(10059):2450. doi: 10.1016/S0140-6736(16)32217-6. Lancet. 2016. PMID: 27871733 No abstract available.
Similar articles
-
Progress Toward Regional Measles Elimination - Worldwide, 2000-2016.MMWR Morb Mortal Wkly Rep. 2017 Oct 27;66(42):1148-1153. doi: 10.15585/mmwr.mm6642a6. MMWR Morb Mortal Wkly Rep. 2017. PMID: 29073125 Free PMC article.
-
Progress Toward Regional Measles Elimination - Worldwide, 2000-2017.MMWR Morb Mortal Wkly Rep. 2018 Nov 30;67(47):1323-1329. doi: 10.15585/mmwr.mm6747a6. MMWR Morb Mortal Wkly Rep. 2018. PMID: 30496160 Free PMC article.
-
Progress toward regional measles elimination - worldwide, 2000-2014.MMWR Morb Mortal Wkly Rep. 2015 Nov 13;64(44):1246-51. doi: 10.15585/mmwr.mm6444a4. MMWR Morb Mortal Wkly Rep. 2015. PMID: 26562349
-
Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: Background and summary.Vaccine. 2018 Jan 11;36 Suppl 1:A35-A42. doi: 10.1016/j.vaccine.2017.10.065. Vaccine. 2018. PMID: 29307368 Review.
-
The unfinished measles immunization agenda.J Infect Dis. 2003 May 15;187 Suppl 1:S1-7. doi: 10.1086/368226. J Infect Dis. 2003. PMID: 12721885 Review.
Cited by
-
Perspective on Global Measles Epidemiology and Control and the Role of Novel Vaccination Strategies.Viruses. 2017 Jan 19;9(1):11. doi: 10.3390/v9010011. Viruses. 2017. PMID: 28106841 Free PMC article. Review.
-
A Rare Coincidence of Measles with Typhoid Fever.Cureus. 2017 Aug 30;9(8):e1630. doi: 10.7759/cureus.1630. Cureus. 2017. PMID: 29104838 Free PMC article.
-
Current perspectives in assessing humoral immunity after measles vaccination.Expert Rev Vaccines. 2019 Jan;18(1):75-87. doi: 10.1080/14760584.2019.1559063. Epub 2018 Dec 26. Expert Rev Vaccines. 2019. PMID: 30585753 Free PMC article. Review.
-
Sero-prevalence of rubella among pregnant women in Sub-Saharan Africa: a meta-analysis.Hum Vaccin Immunother. 2020 Oct 2;16(10):2472-2478. doi: 10.1080/21645515.2020.1729027. Epub 2020 Mar 20. Hum Vaccin Immunother. 2020. PMID: 32195620 Free PMC article.
-
A Major Regional Measles Outbreak: Description of Hospitalized Cases in 2017-2018 at Bordeaux University Hospital, France.Open Forum Infect Dis. 2020 Aug 17;7(9):ofaa332. doi: 10.1093/ofid/ofaa332. eCollection 2020 Sep. Open Forum Infect Dis. 2020. PMID: 33732748 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous